Article Figures & Data
Tables
- Table 1.
Odds ratios (95% confidence intervals) of prostate cancer by quartile of baseline serum 25-hydroxyvitamin D (ng/mL)
Quartile 1 Quartile 2 Quartile 3 Quartile 4 Ptrend Cases/controls 83/75 69/73 57/74 87/75 Range, 25-hydroxyvitamin D (ng/mL) ≤14.79 14.80-18.82 18.83-23.98 >23.98 Unadjusted odds ratio (95% confidence interval) 1.00 0.81 (0.45-1.47) 0.57 (0.30-1.06) 0.87 (0.49-1.57) 0.99 Adjusted* odds ratio (95% confidence interval) 1.00 0.88 (0.48-1.61) 0.59 (0.31-1.11) 0.89 (0.49-1.62) 0.97 ↵* Adjusted for age at randomization, body mass index, and pack-years of smoking.
December 2007
Volume 16, Issue 12
Volume 16, Issue 12
Lack of Association between Serum Levels of 25-Hydroxyvitamin D and the Subsequent Risk of Prostate Cancer in Finnish Men
Jump to section
Advertisement